Alessandra Tucci
Overview
Explore the profile of Alessandra Tucci including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
127
Citations
2320
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Camus V, Thieblemont C, Gaulard P, Cheminant M, Casasnovas R, Ysebaert L, et al.
J Clin Oncol
. 2024 Feb;
42(14):1612-1618.
PMID: 38364196
JCO The primary analysis of the Ro-CHOP phase III randomized controlled trial (ClinicalTrials.gov identifier: NCT01796002) established that romidepsin (Ro) plus cyclophosphamide, doxorubicin, vincristine, prednisone (CHOP) did not yield an increased...
12.
MYC rearrangements in HIV-associated large B-cell lymphomas: EUROMYC, a European retrospective study
Pagani C, Rusconi C, Dalla Pria A, Ravano E, Schommers P, Bastos-Oreiro M, et al.
Blood Adv
. 2024 Jan;
8(4):968-977.
PMID: 38207206
Large B-cell lymphoma (LBCL) carrying MYC rearrangement, alone or together with BCL2 and/or BCL6 translocations, have shown a poor prognosis when treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone...
13.
Tucci A, Masina L, Luminari S
Leuk Lymphoma
. 2024 Jan;
65(5):560-569.
PMID: 38206922
Older patients with aggressive lymphoma are extremely heterogeneous due to the high frequency of functional limitations and comorbidities and to the different biological profiles and clinical behavior of the disease....
14.
Conconi A, Chiappella A, Ferreri A, Stathis A, Botto B, Sassone M, et al.
Blood Adv
. 2024 Jan;
8(6):1541-1549.
PMID: 38181782
Primary testicular diffuse large B-cell lymphoma (PTL) is characterized by high risk of contralateral testis and central nervous system (CNS) relapse. Chemoimmunotherapy with intrathecal (IT) CNS prophylaxis and contralateral testis...
15.
Giupponi C, Bertoli D, Borlenghi E, Cattaneo C, Zollner T, Masina L, et al.
Blood Cancer J
. 2023 Dec;
13(1):194.
PMID: 38129393
No abstract available.
16.
Chen J, Labopin M, Pabst T, Zhang X, Jiang E, Tucci A, et al.
Bone Marrow Transplant
. 2023 Aug;
58(12):1322-1330.
PMID: 37640797
In patients with acute myeloid leukemia (AML) of intermediate-risk (IR) in first remission (CR1) with no measurable residual disease (MRD negative), the choice of the best consolidation is questionable. 1122...
17.
Gini G, Tani M, Tucci A, Marcheselli L, Cesaretti M, Bellei M, et al.
Blood
. 2023 Jul;
142(17):1438-1447.
PMID: 37418685
Treatment of diffuse large B-cell lymphoma (DLBCL) in older patients is challenging, especially for those who are not eligible for anthracycline-containing regimens. Fondazione Italiana Linfomi (FIL) started the FIL_ReRi study,...
18.
Belotti A, Ribolla R, Crippa C, Chiarini M, Giustini V, Ferrari S, et al.
Am J Hematol
. 2023 Jun;
98(9):E230-E232.
PMID: 37317959
No abstract available.
19.
Arcari A, Rigacci L, Tucci A, Puccini B, Usai S, Cavallo F, et al.
Blood Adv
. 2023 Jun;
7(15):4160-4169.
PMID: 37276080
Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) is the most commonly used regimen for the upfront treatment of diffuse large B-cell lymphoma (DLBCL). However, it is associated with cardiotoxicity, especially...
20.
Albano D, Treglia G, Dondi F, Calabro A, Rizzo A, Annunziata S, et al.
Cancers (Basel)
. 2023 May;
15(9).
PMID: 37173962
Recently, several studies introduced the potential prognostic usefulness of maximum tumor dissemination (Dmax) measured by 2-deoxy-2-fluorine-18-fluoro-D-glucose positron-emission tomography/computed tomography (F-FDG PET/CT). Dmax is a simple three-dimensional feature that represents the...